Structure
atLeast majority ProS Experiment
:order disorder conflict PDB cluster ProS Pfam Domain SEG
279
order/disorder by at least rule
disorder by at least rule
order/disorder by majority rule
Seq 1-279 Hetero dimer : IID00052 Complex
Region 3zrk Y 197-200 disorder
Region 3zrk Y 201-222 order
Region 3zrk Y 223-226 disorder
Region 3zrk X 197-198 disorder
Region 3zrk X 199-222 order
Region 3zrk X 223-226 disorder
Region 5oy4 Y 1-198 disorder
Region 5oy4 Y 199-222 order
Region 5oy4 Y 223-279 disorder
Region 5oy4 X 1-198 disorder
Region 5oy4 X 199-223 order
Region 5oy4 X 224-279 disorder
Region 1gng Y 188-197 disorder
Region 1gng Y 198-222 order
Region 1gng Y 223-226 disorder
Region 1gng X 188-197 disorder
Region 1gng X 198-222 order
Region 1gng X 223-226 disorder
Region 4afj Y 197-199 disorder
Region 4afj Y 200-222 order
Region 4afj Y 223-226 disorder
Region 4afj X 197-199 disorder
Region 4afj X 200-222 order
Region 4afj X 223-226 disorder
Seq 197-226 Hetero tetramer : IID00052 Complex
Region 3zrm Y 197-200 disorder
Region 3zrm Y 201-222 order
Region 3zrm Y 223-226 disorder
Region 3zrm X 197-198 disorder
Region 3zrm X 199-221 order
Region 3zrm X 222-226 disorder
Region 3zrl Y 197-200 disorder
Region 3zrl Y 201-222 order
Region 3zrl Y 223-226 disorder
Region 3zrl X 197-198 disorder
Region 3zrl X 199-221 order
Region 3zrl X 222-226 disorder
Seq ProS possible 198-222
Hetero dimer : IID00052 Complex
Region 1gng X 198-222 order
Region 1gng Y 198-222 order
Region 3zrk X 199-222 order
Region 3zrk Y 201-222 order
Region 4afj X 200-222 order
Region 4afj Y 200-222 order
Seq ProS possible 198-222
Hetero tetramer : IID00052 Complex
Region 3zrm X 199-221 order
Region 3zrm Y 201-222 order
Region 3zrl X 199-221 order
Region 3zrl Y 201-222 order
Prediction
Disorder 1-22,37-40,59-196,229-279
Order 23-36,41-58,197-228
ProS 1-5,37-40,91-94,109-123,168-196,251-279
Disorder 1-23,25-25,27-29,31-31,54-197,230-276,278-279
Order 24-24,26-26,30-30,32-53,198-229,277-277
SEG 6-22
,59-83
,89-100
,247-256
Function
Function in SwissProt
Positively regulates the Wnt signaling pathway by stabilizing beta-catenin through the association with GSK-3. May play a role in tumor progression and collaborate with PIM1 and MYC in lymphomagenesis.